3782 Envelope glycoprotein GP2-related
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 0 | 9.7 | 0 | q < 0.0001 | |
| Nucleosides, nucleotides, and analogues | 0 | 5.5 | 0 | q = 8.0e-3 | |
| Organic oxygen compounds | 12 | 3.9 | 3.06× | not tested | |
| Phenylpropanoids and polyketides | 1 | 0.4 | 2.44× | not tested | |
| Homogeneous non-metal compounds | 8 | 4.2 | 1.89× | not tested | |
| Benzenoids | 2 | 1.4 | 1.39× | not tested | |
| Organoheterocyclic compounds | 2 | 3.0 | 0.66× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 81 |
| DB00245 | CXQ | Benzatropine | 1 |
| DB00458 | IXX | Imipramine | 1 |
| DB00539 | T0R | Toremifene | 1 |
| DB00715 | 8PR | Paroxetine | 1 |
| DB01104 | SRE | Sertraline | 1 |
| DB01242 | CXX | Clomipramine | 1 |
| DB09213 | IBP | Dexibuprofen | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 43 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 18 |
| MAN | alpha-D-mannopyranose | 3 |
| 8PR | Paroxetine | 1 |
| A1BZF | N-{3-[(1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1-phenylbut-1-en-2-yl]phenyl}-N'-[(3R)-oxolan-3-yl]sulfuric diamide | 1 |
| CQN | Bepridil | 1 |
| CXQ | benztropine | 1 |
| CXX | 3-(3-CHLORO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE | 1 |
| GKZ | 1-[2-[4-[4-(4-chlorophenyl)-3-methyl-1~{H}-pyrazol-5-yl]-3-oxidanyl-phenoxy]ethyl]piperidin-1-ium-4-carboxamide | 1 |
| GON | 1-[2-[3-oxidanyl-4-(4-phenyl-1~{H}-pyrazol-5-yl)phenoxy]ethyl]piperidine-4-carboxamide | 1 |
| IBP | IBUPROFEN | 1 |
| IXX | 3-(5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE | 1 |
| KHG | (1S,3R,5R,7S)-N-(trans-4-aminocyclohexyl)-3-methyl-5-phenyltricyclo[3.3.1.1~3,7~]decane-1-carboxamide | 1 |
| MRD | (4R)-2-METHYLPENTANE-2,4-DIOL | 1 |
| RTZ | 10-{2-[(2R)-1-methylpiperidin-2-yl]ethyl}-2-(methylsulfanyl)-10H-phenothiazine | 1 |
| SRE | (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine | 1 |
| T0R | Toremifene | 1 |
| XJ5 | [(4S)-4-amino-3,3-dimethylpiperidin-1-yl][(1S,3R,5R,7S)-3-methyl-5-phenyladamantan-1-yl]methanone | 1 |
| YOD | (1R,3S,5S,7S)-N-[(1r,4R)-4-aminocyclohexyl]-3-[(methylsulfanyl)methyl]-5-phenyladamantane-1-carboxamide | 1 |
| YPM | (1s,3R,5S,7s)-N-[(1r,4r)-4-aminocyclohexyl]-3,5-diphenyladamantane-1-carboxamide | 1 |